CPP
CTSO icon

Crow Point Partners’s Cytosorbents Corp CTSO Stock Holding History

Crow Point Partners’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,100
Closed -$214K – 88
2019
Q3 		$214K Sell
2,100
-168
-7% -$19.5K 0.03% 106
2019
Q2 		$300K Sell
2,268
-483
-18% -$66.4K 0.05% 82
2019
Q1 		$417K Buy
2,751
+322
+13% +$50.1K 0.07% 64
2018
Q4 		$380K Buy
2,429
+29
+1% +$5.76K 0.07% 68
2018
Q3 		$619K Buy
2,400
+148
+7% +$37.1K 0.11% 69
2018
Q2 		$518K Buy
2,252
+1,719
+323% +$325K 0.1% 70
2018
Q1 		$75K Buy
533
+82
+18% +$12.4K 0.01% 163
2017
Q4 		$59K Buy
+451
New +$57.4K 0.01% 195

Other funds holding CTSO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Skylands Capital
Skylands Capital Milwaukee, Wisconsin $762M AUM 14.92% 1-Year Est. Return
Granahan Investment Management
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sargent Investment Group
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Avenir Corporation
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return

Crow Point Partners's CTSO Position: Q4 2019 in Review

Crow Point Partners sold out of Cytosorbents Corp (CTSO) in Q4 2019, closing a stake of 2,100 shares — an estimated $214K sold.

Crow Point Partners first reported a position in CTSO in Q4 2017 and held it in 8 quarters. The position peaked at $619K in Q3 2018. 72 funds tracked by Wall St. Rank hold CTSO as of Q4 2019.

  • Crow Point Partners reported no remaining Cytosorbents Corp position as of Q4 2019 after selling out during the quarter.
  • Crow Point Partners sold 2,100 Cytosorbents Corp shares in Q4 2019, an estimated $214K.
  • Crow Point Partners first reported a position in Cytosorbents Corp in Q4 2017 and held it in 8 quarters.
  • Crow Point Partners's Cytosorbents Corp position peaked at $619K in Q3 2018.
  • 72 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2019.

Based on Crow Point Partners's 13F filing for Q4 2019, filed 14 Feb 2020.